Postpartum Vaccines and Contraception Integration for Birth Control
(PIVoT Trial)
Trial Summary
What is the purpose of this trial?
This study aims to examine how to implement a gender-transformative post-partum family planning program integrated into community-based infant vaccination services, and to evaluate preliminary effectiveness of this approach on postpartum contraceptive use in a low resource, rural setting.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Postpartum Vaccines and Contraception Integration for Birth Control is an effective treatment?
The available research shows that integrating family planning into postpartum care can significantly increase the use of contraception among new mothers. For example, in Afghanistan, after implementing a program to integrate family planning into postpartum care, the proportion of women who received family planning counseling before leaving the hospital increased from 36% to 55%. Additionally, the number of women who left the hospital with their preferred contraceptive method rose from 12% to 95%. This suggests that providing contraception and counseling during the postpartum period is effective in helping women plan their families and reduce the likelihood of unintended pregnancies.12345
What safety data exists for postpartum vaccines and contraception integration?
The provided research does not directly address safety data for the specific treatment of postpartum vaccines and contraception integration. However, it highlights the importance of contraception in the postpartum period, the need for tailored contraceptive methods, and the significance of counseling. It also discusses the development of multipurpose prevention technologies and the importance of considering user preferences, which may indirectly relate to safety considerations. More specific studies or data would be needed to directly address the safety of the treatment in question.36789
Is the treatment in the trial 'Postpartum Vaccines and Contraception Integration for Birth Control' a promising treatment?
Yes, integrating family planning with postpartum care, like vaccines and health visits, is promising because it helps women access contraception more easily after childbirth. This approach can reduce unplanned pregnancies and improve maternal and infant health by providing timely and repeated opportunities for women to learn about and use contraception.1011121314
Research Team
Sarah Averbach, MD, MAS
Principal Investigator
University of California, San Diego
Shahina Begum, PhD
Principal Investigator
Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health
Eligibility Criteria
This trial is for postpartum women who speak Marathi, delivered a baby within the last 8 weeks, live in rural Maharashtra, and have not had sterilization or certain immediate post-birth contraceptive procedures. Pregnant women cannot participate.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Postpartum Integration of Vaccines and Contraception Through Gender-Transformative Programming(PIVoT) (Cancer Vaccine)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
Dr. Christopher Longhurst
University of California, San Diego
Chief Medical Officer since 2021
MD and MS in Medical Informatics from UC Davis
Patty Maysent
University of California, San Diego
Chief Executive Officer since 2016
MBA from Stanford University
Indian Council of Medical Research
Collaborator
Dr. Rajiv Bahl
Indian Council of Medical Research
Chief Executive Officer since 2022
MD in Pediatrics from University of Delhi, PhD in Public Health from All India Institute of Medical Sciences
Dr. Sanghamitra Pati
Indian Council of Medical Research
Chief Medical Officer
MBBS and MD from MKCG Medical College, MPH from University of Maastricht, PhD from University of Maastricht